These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Are some progestins genotoxic liver carcinogens? Brambilla G; Martelli A Mutat Res; 2002 Dec; 512(2-3):155-63. PubMed ID: 12464349 [TBL] [Abstract][Full Text] [Related]
45. International Commission for Protection Against Environmental Mutagens and Carcinogens. Genotoxicity under extreme culture conditions. A report from ICPEMC Task Group 9. Scott D; Galloway SM; Marshall RR; Ishidate M; Brusick D; Ashby J; Myhr BC Mutat Res; 1991 Mar; 257(2):147-205. PubMed ID: 2005937 [No Abstract] [Full Text] [Related]
47. Role of oxidative stress in the mechanism of dieldrin's hepatotoxicity. Bachowski S; Kolaja KL; Xu Y; Ketcham CA; Stevenson DE; Walborg EF; Klaunig JE Ann Clin Lab Sci; 1997; 27(3):196-209. PubMed ID: 9142372 [TBL] [Abstract][Full Text] [Related]
48. The clastogenicity of chemicals in cultured mammalian cells. Ishidate M; Harnois MC Mutagenesis; 1987 May; 2(3):240-3. PubMed ID: 3325752 [No Abstract] [Full Text] [Related]
49. Liver cell proliferation and tumor promotion by phenobarbital: relevance for humans? Braeuning A Arch Toxicol; 2014 Oct; 88(10):1771-2. PubMed ID: 25141972 [No Abstract] [Full Text] [Related]
50. Carcinogenicity testing of drugs. Williams GM; Weisburger JH Prog Drug Res; 1985; 29():155-213. PubMed ID: 3911261 [No Abstract] [Full Text] [Related]
51. Classification of genotoxic and epigenetic hepatocarcinogens using liver culture assays. Williams GM Ann N Y Acad Sci; 1980; 349():273-82. PubMed ID: 6939363 [No Abstract] [Full Text] [Related]
52. Osmotic-sensitive mutants of Saccharomyces cerevisiae as screening organisms for promutagens and procarcinogens. Morita T; Yanagihara Y Chem Pharm Bull (Tokyo); 1985 Apr; 33(4):1576-82. PubMed ID: 3899386 [No Abstract] [Full Text] [Related]
54. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC publication No. 5: An evaluation of the genetic toxicity of dichlorvos. Ramel C; Drake J; Sugimura T Mutat Res; 1980 Nov; 76(3):297-309. PubMed ID: 6782471 [No Abstract] [Full Text] [Related]
55. Can nongenotoxic carcinogens be detected with the lacI transgenic mouse mutation assay? Gunz D; Shephard SE; Lutz WK Environ Mol Mutagen; 1993; 21(3):209-11. PubMed ID: 8462524 [No Abstract] [Full Text] [Related]
56. Appreciation of the value of different bacterial test systems for detecting and for ranking chemical mutagens. Mohn GR; Ellenberger J Arch Toxicol; 1980 Nov; 46(1-2):45-60. PubMed ID: 7235998 [No Abstract] [Full Text] [Related]
57. Isoniazid--an attempt at retrospective prediction. A report of an ad hoc expert groups of the International Commission for Protection Against Environmental Mutagens and Carcinogens. Mutat Res; 1980 Jul; 76(1):85-112. PubMed ID: 6993938 [No Abstract] [Full Text] [Related]
58. The carcinogenicity of dieldrin. Part I. Epstein SS Sci Total Environ; 1975 May; 4(1):1-52. PubMed ID: 1096299 [No Abstract] [Full Text] [Related]
59. The concept of activity profiles of antimutagens. Waters MD; Brady AL; Stack HF; Brockman HE Basic Life Sci; 1990; 52():87-104. PubMed ID: 2183787 [No Abstract] [Full Text] [Related]
60. An interesting state of affairs in genetic toxicology. Zeiger E Environ Mol Mutagen; 2000; 35(2):82-5. PubMed ID: 10712741 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]